Latest Insider Transactions at Amneal Pharmaceuticals, Inc. (AMRX)
This section provides a real-time view of insider transactions for Amneal Pharmaceuticals, Inc. (AMRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Amneal Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Amneal Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2020
|
John Kiely Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,522
+30.04%
|
-
|
|
Dec 15
2020
|
Shlomo Yanai Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,522
+50.0%
|
-
|
|
Aug 06
2019
|
Fosun International LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
327,000
+50.0%
|
$654,000
$2.91 P/Share
|
|
Aug 05
2019
|
Fosun International LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,642,300
+50.0%
|
$4,926,900
$3.04 P/Share
|